Skip to content

Alinity 08P2030Recalls & reported problems

Abbott GmbH · Alinity c Alkaline Phosphatase Reagent Kit 10750 Tests · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380740135171), received between Jan 29, 2024 and Jan 29, 2024 — classified as 1 malfunction.

The most frequently reported specific device problem is “Computer Software Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Computer Software Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 29, 2024Computer Software Problem; Computer Software Problem

    THE CUSTOMER OBSERVED ALKALINE PHOSPHATASE IFCC (INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY) CONVERSION FACTOR NOT ENTERED IN ASSAY PARAMETER SETTING BY THE ABBOTT FIELD SERVICE REPRESENTATIVE (FSR), AT THE TIME OF MULTIPLE ALINITY CI PROCESSING MODULES SETUP. THE CUSTOMER REQUESTED IFCC METHOD FOR ALKALINE PHOSPHATASE ON ALINITY CI PROCESSING MODULE SINCE (B)(6) 2022 DURING THE TIME OF ALINITY CI SETUP. THE ALKALINE PHOSPHATASE IFCC SHOULD HAVE CALIBRATION FACTOR 2290 AND NON-IFCC CALIBRATION FACTOR 2150. THE CUSTOMER NOTICED THE NON-IFCC CALIBRATION FACTOR 2150 WHEN DOING NEW ALKALINE PHOSPHATASE REAGENT CALIBRATION, AT THAT TIME FIND OUT ABOUT THIS ISSUE. THERE SHOULD BE CONVERSION FACTOR ON ASSAY PARAMETER SETTING WHEN SELECT UNIT OF MEASURE THEN NEED TO ENTER CONVERSION FACTOR 1.0651 FOR IFCC METHOD AND THAT WAS NOT ENTERED BY THE FSR AT THE TIME OF SETUP OF ALINITY CI PROCESSING MODULE. THERE WAS NO INFORMATION PROVIDED BY THE CUSTOMER FOR DISCREPANT ALKALINE PHOSPHATASE RESULTS. THERE WAS NO TREATMENT CHANGED DUE TO DISCREPANT ALKALINE PHOSPHATASE RESULTS REPORTED. NO FURTHER IMPACT TO PATIENT MANAGEMENT REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18597883 ↗

Other NITROPHENYLPHOSPHATE, ALKALINE PHOSPHATASE OR ISOENZYMES devices

All NITROPHENYLPHOSPHATE, ALKALINE PHOSPHATASE OR ISOENZYMES devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.